Showing results (121-130 of 213) with videos related to

Sort By:
Pageof 22
The American Journal of Gastroenterology|July 10, 2007
Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?Franco Trevisani, Valentina Santi, Annagiulia Gramenzi, et al.
Scandinavian Journal of Gastroenterology|April 25, 2007
Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: relationship with renal functionAndrea Zambruni, Franco Trevisani, Veit Gülberg, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 7, 2017
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbàra, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 4, 2014
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosisPaolo Del Poggio, Stefano Olmi, Francesca Ciccarese, et al.
BMC Cancer|July 7, 2018
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysisCarla Rognoni, Oriana Ciani, Silvia Sommariva, et al.
Seminars in Oncology|July 16, 2014
Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parametersBrian I Carr, Petr Pancoska, Edoardo G Giannini, et al.
Seminars in Oncology|May 3, 2014
Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotypeBrian I Carr, Vito Guerra, Edoardo G Giannini, et al.
The American Journal of Gastroenterology|August 17, 2004
Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survivalFranco Trevisani, Maria C Cantarini, Antonello M M Labate, et al.
The Oncologist|November 16, 2013
Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II studyGiovanni Brandi, Francesco de Rosa, Valentina Agostini, et al.
Clinical and Translational Gastroenterology|January 14, 2021
Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With SorafenibVito Sansone, Francesco Tovoli, Andrea Casadei-Gardini, et al.
Pageof 22